CMS Open Payments · Program Year 2024
Prytime Medical Devices, Inc.
Prytime Medical Devices, Inc. reported $1,070,379.04 across General Payments, Research, and Ownership to 311 physicians and teaching hospitals across 373 transactions.
- $1.1M Above-median payer
- All-tracks total
- 373 Above-median volume
- Transactions
- 311 Above-median reach
- Recipients
- +$12.2K
- General Payments vs PY2023
Prytime Medical Devices, Inc. reported $1,070,379.04 across all CMS Open Payments tracks (General + Research + Ownership) to 311 physicians and teaching hospitals in Program Year 2024 - ranking #605 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $265,721.89, averaging $3.4K per recipient.
How Prytime Medical Devices, Inc.'s $1.1M all-tracks total breaks down
Prytime Medical Devices, Inc.'s payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
F
24/100
Total payments
F
20/100
Transaction volume
F
13/100
Physician reach
F
12/100
Payment type diversity
D
50/100
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer prytime-medical-devices-inc Prytime Medical Devices, Inc.
$1.1M · #605/1,925 · 0.0% industry · PY2024
- TOT $1.1M
- RANK #605
- SHARE 0.0%
- TXN 373
- RCP 311
- CAT 4
- GEN $265.7K
- ΔGEN +$12.2K
- TOP1 60.0%
- PY 2024
Volume peers
Nearest volume peer: Verrica Pharmaceuticals Inc. ($1.1M)
Prytime Medical Devices, Inc. sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
Release-over-release change
General Payments changed from PY2023 to PY2024
Prytime Medical Devices, Inc.'s CMS-reported General Payments increased by $12.2K (+4.8%) from PY2023 to PY2024.
How this year-over-year comparison is scoped
The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.
CMS source labels for this exact identifier: PY2022: PRYTIME MEDICAL DEVICES, INC.PY2023: PRYTIME MEDICAL DEVICES, INC.PY2024: Prytime Medical Devices, Inc.. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $253,526.00
- PY2024
- $265,721.89
What the Data Shows for Prytime Medical Devices, Inc.
Three separate CMS disclosure tracks feed the all-tracks total above - General, Research, and Ownership/Investment - each reported under its own rules and combined here for one comparable figure. For Prytime Medical Devices, Inc., that total blends General Payments (day-to-day consulting, meals, travel and speaking fees, shown separately above) with Research and Ownership/Investment interest records, each governed by its own CMS reporting rules. CMS releases each Program Year roughly 12 months after it ends; the methodology page covers the full standardization basis.
The 4-category breakdown below covers general payments only (see our methodology for how research and ownership payments are reported separately). The largest general-payment category is "Consulting Fee" at $202.5K, accounting for 76.2% of this company's General Payments and 15 transactions.
General Payment Breakdown by Type
Prytime Medical Devices, Inc. made 4 types of general payments. "Consulting Fee" is the largest category at $202.5K, 76.2% of General Payments.
Prytime Medical Devices, Inc. reports 4 general-payment categories - the top three are Consulting Fee (76.2%), Travel and Lodging (12.2%), and Food and Beverage (7.7%). The remaining 1 category make up 3.9% of this company's reported general-payment total. That multi-category mix is the kind of profile single-category reporters cannot show.
How Prytime Medical Devices, Inc. divides its payments
General-payment categories, ordered by reported total
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Consulting Fee | $202.5K | 15 | 76.2% |
| Travel and Lodging | $32.4K | 30 | 12.2% |
| Food and Beverage | $20.4K | 262 | 7.7% |
| Compensation for Faculty or Speaker (Medical Education) | $10.4K | 4 | 3.9% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $238,581.94 (89.8%) of $265,721.89 in this company's General Payments records across 176 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Prytime Medical Devices, Inc.
The five named recipients with the highest reported General Payments from this company
- 1
Marshall Spalding
$159,343.67 across 24 reported transactions
- 2
Todd Rasmussen
$45,653.71 across 6 reported transactions
- 3
Jonathan Nguyen
$26,301.38 across 27 reported transactions
- 4
James a Betz
$4,669.80 across 6 reported transactions
- 5
Robert Cohen
$2,613.38 across 8 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Spend vs. Concentration
Prytime Medical Devices, Inc.'s spend rank (#605 of 1,925, top 31% by spend) and concentration rank (#449 of 1,838, top 24% most concentrated) land at roughly the same percentile, an unusually proportionate case where payment size and payment concentration move together.
View all 12 companies in this HHI neighborhood as a list
- Digirad Health, Inc : $95.76 total payments, HHI 4071
- Ecential Robotics : $3.9K total payments, HHI 4050
- CroiValve inc : $1.7K total payments, HHI 4025
- Astellas US LLC : $13.7K total payments, HHI 4023
- Summ Cott Medical : $106.00 total payments, HHI 4021
- Besins Healthcare Ireland Limited : $139.1K total payments, HHI 4012
- Prytime Medical Devices, Inc. (this company) : $265.7K total payments, HHI 3997
- Contego Medical, Inc : $340.5K total payments, HHI 3992
- Microgenics Corporation : $106.3K total payments, HHI 3980
- B. Braun Melsungen AG : $165.4K total payments, HHI 3974
- Dynavax Technologies Corporation : $446.2K total payments, HHI 3923
- Materialise USA LLC : $273.65 total payments, HHI 3922
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Prytime Medical Devices, Inc.'s, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Prytime Medical Devices, Inc..
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Prytime Medical Devices, Inc..
Showing 6 of 1,924 companies with CMS-reported payment data.
Innovasis Inc
Grifols Therapeutics LLC
Bionova Medical Inc
ZOLL Circulation Inc
Cerapedics Inc.
Put this to use
Prytime Medical Devices, Inc. ranks #605 of 1,925 by all-tracks total payments, led by "Consulting Fee".
- See where Prytime Medical Devices, Inc. sits among every top spender on the full leaderboard. Top 100 by total payments
- Compare "Consulting Fee" spend across every manufacturer, not just Prytime Medical Devices, Inc.. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.